Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study.

IF 4.2
Endocrinology and metabolism (Seoul, Korea) Pub Date : 2026-06-01 Epub Date: 2026-03-04 DOI:10.3803/EnM.2025.2524
Xiangyu Qiu, Lanqing Huang, Huize Jiang, Xiahui Ren, Min Tang, Tianhui Yan, Le Xu, Chong Pei, Lei Hu
{"title":"Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study.","authors":"Xiangyu Qiu, Lanqing Huang, Huize Jiang, Xiahui Ren, Min Tang, Tianhui Yan, Le Xu, Chong Pei, Lei Hu","doi":"10.3803/EnM.2025.2524","DOIUrl":null,"url":null,"abstract":"<p><strong>Backgruound: </strong>Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at increased risk of panvascular disease (PD). Noninvasive markers for early risk stratification are needed. We evaluated whether ultrasound-derived fat fraction (UDFF) improves the prediction of PD occurrence in MASLD patients.</p><p><strong>Methods: </strong>In this prospective cohort, 525 adults with MASLD were enrolled between October 2022 and December 2023 and followed for 6 months for PD occurrence. Baseline UDFF and clinical/metabolic variables were collected. Multivariable logistic regression analyses reported standardized coefficients (per-standard deviation [SD] β) and odds ratios (ORs) per 1-SD (OR). A decision tree model was constructed to explore differences across metabolic subgroups, including obesity, hypertension, diabetes, and multiple metabolic abnormalities. Discriminative performance was compared using the area under the curve (AUC; DeLong test).</p><p><strong>Results: </strong>Body mass index (BMI), systolic blood pressure (SBP), homeostasis model assessment of insulin resistance (HOMA-IR), and UDFF were each associated with increased PD risk. In the multivariable model, the strongest standardized effects were observed for UDFF (β=3.28; OR, 2.10; 95% confidence interval [CI], 1.45 to 2.75) and BMI (β=1.87; OR, 1.68; 95% CI, 1.25 to 2.34), followed by SBP (β=1.33; OR, 1.15; 95% CI, 1.03 to 1.26). HOMA-IR (β=0.96; OR, 1.65; 95% CI, 1.30 to 2.15), age (β=0.56; OR, 1.06; 95% CI, 1.01 to 1.12), and liver stiffness measurement (β=0.14; OR, 1.03; 95% CI, 1.01 to 1.07) also showed smaller but significant associations. The decision tree model reflected similar patterns and achieved higher discrimination than logistic regression (AUC 0.85 vs. 0.80, P<0.05).</p><p><strong>Conclusion: </strong>UDFF is a key predictor of PD risk in MASLD patients, underscoring the importance of risk stratification for early intervention and personalized management strategies.</p>","PeriodicalId":520607,"journal":{"name":"Endocrinology and metabolism (Seoul, Korea)","volume":" ","pages":"415-427"},"PeriodicalIF":4.2000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13352115/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinology and metabolism (Seoul, Korea)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3803/EnM.2025.2524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Backgruound: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at increased risk of panvascular disease (PD). Noninvasive markers for early risk stratification are needed. We evaluated whether ultrasound-derived fat fraction (UDFF) improves the prediction of PD occurrence in MASLD patients.

Methods: In this prospective cohort, 525 adults with MASLD were enrolled between October 2022 and December 2023 and followed for 6 months for PD occurrence. Baseline UDFF and clinical/metabolic variables were collected. Multivariable logistic regression analyses reported standardized coefficients (per-standard deviation [SD] β) and odds ratios (ORs) per 1-SD (OR). A decision tree model was constructed to explore differences across metabolic subgroups, including obesity, hypertension, diabetes, and multiple metabolic abnormalities. Discriminative performance was compared using the area under the curve (AUC; DeLong test).

Results: Body mass index (BMI), systolic blood pressure (SBP), homeostasis model assessment of insulin resistance (HOMA-IR), and UDFF were each associated with increased PD risk. In the multivariable model, the strongest standardized effects were observed for UDFF (β=3.28; OR, 2.10; 95% confidence interval [CI], 1.45 to 2.75) and BMI (β=1.87; OR, 1.68; 95% CI, 1.25 to 2.34), followed by SBP (β=1.33; OR, 1.15; 95% CI, 1.03 to 1.26). HOMA-IR (β=0.96; OR, 1.65; 95% CI, 1.30 to 2.15), age (β=0.56; OR, 1.06; 95% CI, 1.01 to 1.12), and liver stiffness measurement (β=0.14; OR, 1.03; 95% CI, 1.01 to 1.07) also showed smaller but significant associations. The decision tree model reflected similar patterns and achieved higher discrimination than logistic regression (AUC 0.85 vs. 0.80, P<0.05).

Conclusion: UDFF is a key predictor of PD risk in MASLD patients, underscoring the importance of risk stratification for early intervention and personalized management strategies.

超声来源脂肪分数和代谢参数预测代谢功能障碍相关脂肪变性肝病患者泛血管疾病风险:一项前瞻性研究
背景:代谢功能障碍相关脂肪变性肝病(MASLD)患者发生泛血管疾病(PD)的风险增加。需要无创标志物进行早期风险分层。我们评估超声来源脂肪分数(UDFF)是否能提高对MASLD患者PD发生的预测。方法:在这一前瞻性队列研究中,525名MASLD成年患者在2022年10月至2023年12月期间入组,随访6个月,观察PD的发生情况。收集基线UDFF和临床/代谢变量。多变量logistic回归分析报告了标准化系数(每标准差[SD] β)和每1-SD (OR)的优势比(ORs)。构建决策树模型来探讨代谢亚组之间的差异,包括肥胖、高血压、糖尿病和多种代谢异常。采用曲线下面积(AUC; DeLong test)比较鉴别性能。结果:体重指数(BMI)、收缩压(SBP)、胰岛素抵抗稳态模型评估(HOMA-IR)和UDFF均与PD风险增加相关。在多变量模型中,UDFF (β=3.28; OR, 2.10; 95%可信区间[CI], 1.45至2.75)和BMI (β=1.87; OR, 1.68; 95% CI, 1.25至2.34)的标准化效应最强,其次是收收压(β=1.33; OR, 1.15; 95% CI, 1.03至1.26)。HOMA-IR (β=0.96; OR, 1.65; 95% CI, 1.30至2.15)、年龄(β=0.56; OR, 1.06; 95% CI, 1.01至1.12)和肝脏硬度测量(β=0.14; OR, 1.03; 95% CI, 1.01至1.07)也显示出较小但显著的相关性。结论:UDFF是MASLD患者PD风险的关键预测因子,强调了风险分层对早期干预和个性化管理策略的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书